The meta-analysis of COMMD1 transcripts demonstrated that NSCLC patients had significantly higher levels of COMMD1 than control normal tissue, irrespective of the NSCLC subtype or the tumor grade. The gene discussed is COMMD1; the disease is neoplasm.